|

HH2853 Tablets Clinical Trials

2 actively recruiting trials across 1 location

Also known as: HH2853

Other1 trial

Study to Evaluate Efficacy and Safety of HH2853 in Relapsed/Refractory Peripheral T-cell Lymphoma
Phase 1/2

Phoenix, Arizona1 trial

Evaluate the Safety and Clinical Activity of HH2853

Mayo Clinic

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.